openPR Logo

Press Releases from Exactitude Consultancy (18671 total)

Epstein-Barr Virus (EBV) Market Growth, Applications, Innovations and Business O …

Introduction The Epstein-Barr Virus (EBV), a member of the herpesvirus family, is one of the most common human viruses. It infects over 90% of the global

Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Mark …

Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Market Outlook 2024-2034: Rising Antimicrobial Resistance Spurs Innovation in Antibiotics and Diagnostics Introduction Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia

Interstitial Cystitis Market is projected to reach USD 4.3 billion by 2034

Interstitial Cystitis (IC), also known as bladder pain syndrome (BPS), is a chronic urological condition characterized by pelvic pain, urinary urgency, and increased frequency without

Cytomegalovirus (CMV) Infection Market Set to Witness Significant Growth by 2025 …

Introduction Cytomegalovirus (CMV) is a common herpesvirus infection that affects people of all ages. While usually asymptomatic in healthy individuals, CMV can cause severe complications in

Clostridioides difficile Infection (CDI) Market 2025-2034 Business Outlook, Crit …

Introduction Clostridioides difficile infection (CDI) is a leading cause of healthcare-associated infections worldwide, primarily affecting patients undergoing broad-spectrum antibiotic therapy. CDI leads to severe diarrhea, colitis,

Klebsiella Pneumoniae Infections Market is projected to reach USD 5.0 billion by …

Klebsiella pneumoniae is a Gram-negative bacterium responsible for a wide range of healthcare- and community-acquired infections, including pneumonia, bloodstream infections, urinary tract infections (UTIs), and

Listeriosis Market to Reach USD 670 Million by 2034

Listeriosis is a serious infection caused by Listeria monocytogenes, a foodborne pathogen associated with contaminated dairy, meat, seafood, and ready-to-eat products. Although relatively rare, listeriosis

Necrotizing Enterocolitis (NEC) Market to Reach USD 1.4 Billion by 2034

Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease that primarily affects premature and low-birth-weight infants. It is characterized by intestinal inflammation, necrosis, and in some

Prosthetic Joint Infection (PJI) Market to Reach USD 3.4 Billion by 2034

Prosthetic Joint Infection (PJI) is a severe complication that can occur after joint replacement surgeries, including hip, knee, shoulder, and other prosthetic implants. Although relatively

Traveler's Diarrhea Market to Reach USD 1.6 Billion by 2034

Traveler's diarrhea (TD) is the most common illness affecting international travelers, typically caused by bacterial pathogens such as Escherichia coli (ETEC), Shigella, Campylobacter, and Salmonella,

AIDS Dementia Market to Reach USD 2.7 Billion by 2034

AIDS dementia, also known as HIV-associated neurocognitive disorder (HAND) or HIV-associated dementia (HAD), is a neurological complication that occurs in advanced stages of HIV infection.

Bacteremia Market to Reach USD 9.8 Billion by 2034

Bacteremia is a potentially life-threatening condition characterized by the presence of bacteria in the bloodstream, often resulting from infections such as pneumonia, urinary tract infections

Neurofibromatosis Type 1-Associated Plexiform Neurofibromas (NF1-PN) Market to R …

Neurofibromatosis type 1 (NF1) is a rare, genetic tumor predisposition disorder caused by mutations in the NF1 gene. Among its manifestations, plexiform neurofibromas (PNs) are

Candidemia Market Growth, Trends, Consumer Demand and Key Opportunities

Introduction Candidemia, a bloodstream infection caused by Candida species, is one of the most severe forms of invasive candidiasis. It represents a major healthcare challenge worldwide,

Tuberous Sclerosis Complex (TSC) Market to Reach USD 4.6 Billion by 2034

Tuberous Sclerosis Complex (TSC) is a rare, genetic multisystem disorder caused by mutations in the TSC1 or TSC2 genes. It is characterized by the development

Retinitis Pigmentosa (RP) Market to Reach USD 1.65 Billion by 2034

Retinitis Pigmentosa (RP) is a group of rare, inherited retinal disorders that cause progressive degeneration of photoreceptor cells (rods and cones) in the retina, leading

Aspergillosis Market Set to Witness Significant Growth by 2025-2034

Introduction Aspergillosis is a group of fungal infections caused by the Aspergillus species, a common mold found in the environment. While exposure is frequent, serious illness

Niemann-Pick Disease Type C (NPC) Market to Reach USD 610 Million by 2034

Niemann-Pick Disease Type C (NPC) is a rare, progressive, neurodegenerative lysosomal storage disorder caused by mutations in the NPC1 or NPC2 genes. These mutations impair

Seasonal Influenza Market 2025-2034 Business Outlook, Critical Insight and Growt …

Introduction Seasonal influenza, commonly known as the flu, is an acute viral infection caused by influenza viruses A and B. It remains one of the most

Human Immunodeficiency Virus Type 1 (HIV-1) Market to Set Phenomenal Growth From …

Introduction Human Immunodeficiency Virus Type 1 (HIV-1) remains the most common and widespread form of HIV infection, responsible for the global HIV/AIDS epidemic. Despite decades of

Von Hippel-Lindau (VHL) Disease Market to Reach USD 890 Million by 2034

Von Hippel-Lindau (VHL) disease is a rare, inherited genetic disorder caused by mutations in the VHL tumor suppressor gene. It predisposes individuals to the development

Hereditary Transthyretin Amyloidosis (hATTR) Market is expected to reach USD 9.2 …

Hereditary transthyretin amyloidosis (hATTR) is a rare, progressive, life-threatening disease caused by mutations in the TTR gene, leading to the misfolding of transthyretin protein and

X-Linked Myotubular Myopathy (XLMTM) Market to Reach USD 520 Million by 2034

X-Linked Myotubular Myopathy (XLMTM) is a rare, inherited neuromuscular disorder caused by mutations in the MTM1 gene, which disrupts the production of myotubularin. This leads

Genital Warts (Condyloma Acuminatum) Market New Product Development & Latest Tre …

Introduction Genital warts, also known as condyloma acuminatum, are among the most common sexually transmitted infections (STIs), caused by certain strains of the human papillomavirus (HPV),

Triple X Syndrome Market to Reach USD 400 Million by 2034

Triple X syndrome, also known as 47,000 or Trisomy X, is a rare chromosomal disorder in females caused by the presence of an extra X

Chronic Hepatitis B (CHB) Market Set to Witness Significant Growth by 2025-2034

Introduction Chronic Hepatitis B (CHB) is a serious viral infection of the liver caused by the hepatitis B virus (HBV). It remains a major global public

Tay-Sachs disease market is expected to reach USD 710 million by 2034

Tay-Sachs disease is a rare, inherited lysosomal storage disorder caused by mutations in the HEXA gene, leading to deficiency of the enzyme beta-hexosaminidase A. This

Von Willebrand Disease (VWD) Market 2025-2034 Business Outlook, Critical Insight …

Introduction Von Willebrand Disease (VWD) is the most common inherited bleeding disorder, caused by deficiencies or dysfunction in the von Willebrand factor (VWF), a protein essential

Recessive Dystrophic Epidermolysis Bullosa (RDEB) market is expected to reach US …

Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a rare, inherited connective tissue disorder caused by mutations in the COL7A1 gene, which impairs the production of type

Sickle Cell Disease (SCD) Market 2025-2034 Business Outlook, Critical Insight an …

Introduction Sickle Cell Disease (SCD) is a group of inherited blood disorders caused by mutations in the hemoglobin gene, leading to abnormally shaped red blood cells.

Prader-Willi Syndrome (PWS) Market Insights and Future Outlook

Introduction Prader-Willi Syndrome (PWS) is a complex and rare genetic disorder caused by the loss of function of specific genes on chromosome 15. It is characterized

Epidermolysis Bullosa (EB) Market to Set Phenomenal Growth From 2025 to 2034

Introduction Epidermolysis Bullosa (EB) is a group of rare, inherited skin disorders characterized by extreme fragility of the skin, leading to blistering and wounds even from

Hereditary Transthyretin Amyloidosis (hATTR) Market New Product Development & La …

Introduction Hereditary Transthyretin Amyloidosis (hATTR) is a rare, life-threatening genetic condition caused by mutations in the transthyretin (TTR) gene. These mutations lead to misfolded proteins that

Alpha-1 Antitrypsin Deficiency (AATD) Market Emerging Trends and Growth Prospect …

Introduction Alpha-1 Antitrypsin Deficiency (AATD) is a rare genetic disorder that can cause progressive lung conditions such as emphysema, chronic obstructive pulmonary disease (COPD), and liver

Microscopic Polyangiitis (MPA) market is expected to reach USD 1.45 billion by 2 …

Microscopic polyangiitis (MPA) is a rare, systemic autoimmune disorder characterized by necrotizing vasculitis of small- and medium-sized blood vessels. It often affects the kidneys, lungs,

Lassa fever market is expected to reach USD 210 million by 2034

Lassa fever is an acute viral hemorrhagic illness caused by the Lassa virus, an arenavirus endemic to West Africa. It spreads primarily through contact with

Invasive Aspergillosis (IA) Market is expected to reach USD 7.5 billion by 2034

Invasive aspergillosis (IA) is a severe fungal infection caused by Aspergillus species, primarily affecting immunocompromised patients such as those with hematologic malignancies, stem cell or

Human Papillomavirus 16 (HPV16) Positive Cancers Market is expected to reach USD …

Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide, and HPV16 is the most oncogenic strain, responsible for more than 50% of cervical

Herpes Simplex Virus (HSV) market is expected to reach USD 9.0 billion by 2034

Herpes simplex virus (HSV) is a common viral infection caused by two types: HSV-1, which typically causes oral herpes (cold sores), and HSV-2, which primarily

Helicobacter pylori (H. pylori) Infections Market is expected to reach $9.1 bill …

Helicobacter pylori (H. pylori) is a spiral-shaped bacterium that colonizes the stomach lining, causing chronic gastritis, peptic ulcers, and significantly increasing the risk of gastric

Epidemic Keratoconjunctivitis (EKC) market is expected to reach USD 1.2 billion …

Epidemic keratoconjunctivitis (EKC) is a highly contagious ocular infection caused primarily by adenoviruses, presenting with severe conjunctival inflammation, corneal involvement, pain, and vision disturbances. Outbreaks

Community-Acquired Bacterial Pneumonia (CABP) Market is expected to reach USD 14 …

Community-acquired bacterial pneumonia (CABP) is a serious lung infection contracted outside hospital or healthcare settings, most commonly caused by Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae,

Chronic Hepatitis B (CHB) market is expected to reach USD 9.8 billion by 2034

Chronic Hepatitis B (CHB) is a serious liver infection caused by the hepatitis B virus (HBV) that persists for more than six months. It can

Athlete's Foot (Tinea Pedis) Market is expected to reach USD 5.9 billion by 2034

Athlete's foot, or tinea pedis, is a highly common contagious fungal infection of the feet caused mainly by Trichophyton species. Symptoms include itching, redness, scaling,

Acute Bacterial Skin and Skin Structure Infections Market is expected to reach $ …

Acute Bacterial Skin and Skin Structure Infections (ABSSSI) are severe bacterial infections of the skin and underlying tissues, including cellulitis, wound infections, and major abscesses.

Onychomycosis Market is expected to reach USD 8.4 billion by 2034

Onychomycosis is a common fungal infection of the nails, caused primarily by dermatophytes, yeasts, and non-dermatophyte molds. It leads to nail discoloration, thickening, brittleness, and

Human Immunodeficiency Virus Type 1 (HIV-1) Market is expected to reach USD 44.7 …

Human Immunodeficiency Virus Type 1 (HIV-1) remains a major global health challenge, responsible for the vast majority of HIV infections worldwide. While it is no

Genital Herpes Market is expected to double, reaching USD 5.8 billion by 2034

Genital herpes is a chronic, sexually transmitted viral infection caused primarily by the herpes simplex virus type 2 (HSV-2), and in some cases by HSV-1.

Catheter-Related Bloodstream Infection (CRBSI) Market is expected to reach USD 3 …

Catheter-related bloodstream infections (CRBSIs) are among the most serious and common hospital-acquired infections, caused when pathogens enter the bloodstream through central venous catheters (CVCs), peripherally

Neurofibroma Market to Reach USD 1.1 Billion by 2034

The global Neurofibroma Market is experiencing steady momentum, driven by increasing prevalence of neurofibromatosis, advancements in molecular diagnostics, and rising research funding for rare genetic

Go To Page:    1 2 3 4 5 6 7 8 9 10 71 72 73 74 75 76 77 78 79 80